News
Just days after a capital-markets day left investors wondering what’s next for Novo Nordisk, the Danish drug giant struck a licensing deal worth over…
Prime Medicine (PRME) shares jumped 8% Friday after the FDA…
“When my father died, his trust was the Bible.”
Top global stories this week: ASML, Tesco, Taiwan Semiconductor among notable names
“Another option would be for me to purchase the condo myself and have him pay…
You don’t have to exit the market to survive a summer lull. Here’s your ‘stay…
Only the wealthiest Americans can bear the costs of long-term care, new research found
Surcharge on luxury units is a gamble that the ultrawealthy won’t leave for low-tax states.
SA Asks: Is Dell an attractive takeover target?

